Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Astronics (ATRO) Financials

Astronics logo
$84.99 +5.61 (+7.07%)
Closing price 05/20/2026 04:00 PM Eastern
Extended Trading
$84.40 -0.59 (-0.69%)
As of 04:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Astronics

Annual Income Statements for Astronics

This table shows Astronics' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
67 48 20 47 52 -116 -26 -36 -26 -16 29
Consolidated Net Income / (Loss)
67 48 20 47 52 -116 -26 -36 -26 -16 29
Net Income / (Loss) Continuing Operations
67 48 20 47 52 -116 -26 -36 -26 -16 29
Total Pre-Tax Income
94 69 25 52 68 -112 -27 -30 -26 -7.87 32
Total Operating Income
99 75 32 64 1.70 -101 -29 -30 -6.67 26 76
Total Gross Profit
188 159 137 181 156 97 65 72 175 220 258
Total Revenue
692 633 624 803 773 503 445 535 689 795 862
Operating Revenue
692 633 624 803 773 503 445 535 689 795 862
Total Cost of Revenue
504 474 487 623 617 406 380 463 515 575 604
Operating Cost of Revenue
504 474 487 623 617 406 380 463 515 575 604
Total Operating Expenses
89 85 105 117 154 198 94 102 181 194 182
Selling, General & Admin Expense
89 85 89 117 143 111 99 102 127 142 138
Research & Development Expense
- - - - - - - - 54 52 43
Total Other Income / (Expense), net
-4.75 -6.10 -7.11 -11 67 -12 1.71 0.25 -20 -34 -44
Interest Expense
4.75 4.35 5.37 9.71 6.14 6.74 6.80 0.00 0.00 10 33
Interest & Investment Income
- - - - - - - -9.42 -23 -22 -13
Other Income / (Expense), net
- -1.74 -1.74 -1.67 73 -4.97 8.52 9.67 3.69 -2.19 0.74
Income Tax Expense
27 20 5.31 5.48 16 3.37 -1.38 5.95 0.11 8.35 2.59
Basic Earnings per Share
$2.29 $1.44 $0.60 $1.45 $1.62 ($3.76) ($0.82) ($1.11) ($0.80) ($0.46) $0.83
Weighted Average Basic Shares Outstanding
25.43M 29.10M 28.59M 65.19M 30.72M 30.89M 31.52M 64.57M 34.52M 35.27M 35.69M
Diluted Earnings per Share
$2.22 $1.40 $0.58 $1.41 $1.60 ($3.76) ($0.82) ($1.11) ($0.80) ($0.46) $0.81
Weighted Average Diluted Shares Outstanding
25.43M 29.10M 28.59M 65.19M 30.72M 30.89M 31.52M 64.57M 34.52M 35.27M 35.69M
Weighted Average Basic & Diluted Shares Outstanding
25.43M 29.10M 28.59M 65.19M 30.72M 30.89M 31.52M 64.57M 34.52M 35.27M 35.69M

Quarterly Income Statements for Astronics

This table shows Astronics' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/30/2024 6/29/2024 9/28/2024 12/31/2024 3/29/2025 6/28/2025 9/27/2025 12/31/2025 4/4/2026
Net Income / (Loss) Attributable to Common Shareholders
-17 6.98 -3.18 1.53 -12 -2.83 9.53 1.31 -11 30 26
Consolidated Net Income / (Loss)
-17 6.98 -3.18 1.53 -12 -2.83 9.53 1.31 -11 30 26
Net Income / (Loss) Continuing Operations
-17 6.98 -3.18 1.53 -12 -2.83 9.53 1.31 -11 30 26
Total Pre-Tax Income
-21 1.53 -4.53 1.26 -5.17 0.58 10 1.85 -12 32 25
Total Operating Income
-14 7.78 1.67 7.55 8.37 8.88 13 4.76 23 35 27
Total Gross Profit
21 40 48 56 55 50 61 53 65 80 75
Total Revenue
163 195 185 198 204 209 206 205 211 240 231
Operating Revenue
163 195 185 198 204 209 206 205 211 240 231
Total Cost of Revenue
142 155 138 143 148 158 145 152 147 160 155
Operating Cost of Revenue
142 155 138 143 148 158 145 152 147 160 155
Total Operating Expenses
35 32 46 48 47 41 48 48 41 45 48
Selling, General & Admin Expense
35 32 33 34 34 41 37 36 31 34 36
Research & Development Expense
- - 13 14 12 - 11 12 10 11 12
Total Other Income / (Expense), net
-6.34 -6.25 -6.20 -6.29 -14 -8.30 -2.96 -2.91 -35 -3.22 -2.45
Interest & Investment Income
-5.99 - -5.76 -5.86 -6.22 - -3.15 -3.10 -2.92 -3.39 -2.34
Other Income / (Expense), net
-0.35 -0.30 -0.44 -0.44 -0.34 -0.97 0.19 0.19 0.19 0.18 -0.11
Income Tax Expense
-3.84 -5.44 -1.35 -0.27 6.57 3.41 0.65 0.54 -1.23 2.63 -0.76
Basic Earnings per Share
($0.51) $0.22 ($0.09) $0.04 ($0.34) ($0.07) $0.27 $0.04 ($0.31) $0.83 $0.71
Weighted Average Basic Shares Outstanding
33.94M 34.52M 34.84M 34.99M 35.26M 35.27M 35.41M 35.41M 35.63M 35.69M 35.84M
Diluted Earnings per Share
($0.51) $0.22 ($0.09) $0.04 ($0.34) ($0.07) $0.26 $0.04 ($0.31) $0.82 $0.67
Weighted Average Diluted Shares Outstanding
33.94M 34.52M 34.84M 34.99M 35.26M 35.27M 35.41M 35.41M 35.63M 35.69M 35.84M
Weighted Average Basic & Diluted Shares Outstanding
33.94M 34.52M 34.84M 34.99M 35.26M 35.27M 35.41M 35.41M 35.63M 35.69M 35.84M

Annual Cash Flow Statements for Astronics

This table details how cash moves in and out of Astronics' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-2.64 -0.66 0.01 -0.92 15 8.51 -11 -16 -2.47 7.12 -0.25
Net Cash From Operating Activities
79 49 38 55 43 37 -5.53 -28 -24 31 75
Net Cash From Continuing Operating Activities
79 49 38 55 43 37 -5.53 -28 -24 31 75
Net Income / (Loss) Continuing Operations
67 48 20 47 52 -116 -26 -36 -26 -16 29
Consolidated Net Income / (Loss)
67 48 20 47 52 -116 -26 -36 -26 -16 29
Depreciation Expense
25 26 27 35 33 32 29 28 26 24 22
Amortization Expense
- - - - - - 0.00 0.00 3.02 3.19 3.04
Non-Cash Adjustments To Reconcile Net Income
5.17 4.85 21 6.70 -9.95 110 17 13 35 51 70
Changes in Operating Assets and Liabilities, net
-19 -30 -30 -34 -32 12 -26 -33 -61 -32 -49
Net Cash From Investing Activities
-74 -15 -130 -20 65 -5.80 3.18 14 -4.11 -8.43 -54
Net Cash From Continuing Investing Activities
-74 -15 -130 -20 65 -5.80 3.18 14 -4.11 -8.43 -54
Purchase of Property, Plant & Equipment
-19 -13 -13 -16 -12 -7.46 -6.03 -7.68 -7.64 -8.43 -32
Acquisitions
-52 0.00 -114 0.00 -29 - - - 0.00 0.00 -22
Divestitures
- - 0.00 0.00 107 0.00 9.21 22 3.54 0.00 0.00
Net Cash From Financing Activities
-6.73 -35 91 -36 -92 -25 -7.51 -1.41 25 -15 -22
Net Cash From Continuing Financing Activities
-6.73 -35 91 -36 -92 -25 -7.51 -1.41 25 -15 -22
Repayment of Debt
-68 -42 -24 -73 -156 -171 -30 -127 -138 -387 -122
Repurchase of Preferred Equity
- - - - - - - - 0.00 0.00 -286
Issuance of Debt
55 20 147 35 117 155 20 126 140 377 411
Issuance of Common Equity
- - - - - - 0.00 0.00 21 0.00 0.00
Other Financing Activities, net
5.97 4.65 - 2.20 -2.29 -1.26 2.50 0.10 2.48 -4.74 -26
Effect of Exchange Rate Changes
-0.83 -0.09 - - 0.15 1.54 -0.80 -0.64 0.16 -0.49 1.10
Cash Interest Paid
4.73 4.54 4.78 9.71 5.71 5.83 5.95 7.61 18 19 8.98
Cash Income Taxes Paid
33 16 11 12 27 -1.54 -1.25 -9.98 1.96 3.54 12

Quarterly Cash Flow Statements for Astronics

This table details how cash moves in and out of Astronics' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/30/2024 6/29/2024 9/28/2024 12/31/2024 3/29/2025 6/28/2025 9/27/2025 12/31/2025 4/4/2026
Net Change in Cash & Equivalents
3.36 3.66 -4.70 -2.22 1.97 12 7.52 -12 6.12 -1.40 -6.31
Net Cash From Operating Activities
-1.13 -1.67 2.04 -6.26 8.37 26 21 -7.63 34 28 11
Net Cash From Continuing Operating Activities
-1.13 -1.67 2.04 -6.26 8.37 26 21 -7.63 34 28 11
Net Income / (Loss) Continuing Operations
-17 6.98 -3.18 1.53 -12 -2.83 9.53 1.31 -11 30 26
Consolidated Net Income / (Loss)
-17 6.98 -3.18 1.53 -12 -2.83 9.53 1.31 -11 30 26
Depreciation Expense
6.39 6.35 6.33 6.20 6.04 5.89 5.59 5.38 5.16 5.71 5.89
Amortization Expense
0.79 0.88 0.83 0.86 1.02 0.48 0.60 0.61 0.59 1.23 0.61
Non-Cash Adjustments To Reconcile Net Income
17 12 11 5.63 17 18 12 4.01 42 12 6.14
Changes in Operating Assets and Liabilities, net
-8.30 -28 -13 -20 -3.69 4.56 -6.71 -19 -2.18 -21 -28
Net Cash From Investing Activities
-2.23 -1.50 -1.60 -1.80 -1.85 -3.18 -2.11 -4.61 -18 -29 -11
Net Cash From Continuing Investing Activities
-2.23 -1.50 -1.60 -1.80 -1.85 -3.18 -2.11 -4.61 -18 -29 -11
Purchase of Property, Plant & Equipment
-2.23 -1.61 -1.60 -1.80 -1.85 -3.18 -2.11 -4.61 -13 -12 -11
Net Cash From Financing Activities
6.83 6.66 -5.04 5.85 -4.71 -11 -11 -1.18 -10 0.21 -5.50
Net Cash From Continuing Financing Activities
6.83 6.66 -5.04 5.85 -4.71 -11 -11 -1.18 -10 0.21 -5.50
Repayment of Debt
-13 -5.56 -8.11 -3.29 -185 -195 -11 -1.18 -7.42 -102 -30
Issuance of Debt
4.00 4.00 1.36 14 181 181 1.14 - 310 100 30
Other Financing Activities, net
3.11 -0.00 1.71 -4.90 0.02 2.98 -1.73 - -27 2.48 -5.44
Effect of Exchange Rate Changes
-0.12 0.18 -0.10 -0.01 0.16 - 0.35 0.93 -0.22 0.04 -0.26
Cash Interest Paid
- 3.55 5.00 - - 3.98 2.72 0.24 4.63 1.38 2.67
Cash Income Taxes Paid
- -0.23 0.03 - - -0.44 0.83 12 -0.21 -1.03 0.20

Annual Balance Sheets for Astronics

This table presents Astronics' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
609 604 736 775 783 620 609 615 634 649 707
Total Current Assets
250 255 315 374 343 317 340 365 390 426 438
Cash & Equivalents
19 18 18 17 32 40 30 14 4.76 9.29 18
Accounts Receivable
95 109 133 182 148 93 107 148 172 191 205
Inventories, net
115 117 150 139 146 157 158 188 192 200 197
Prepaid Expenses
21 11 15 17 16 26 45 16 15 17 18
Plant, Property, & Equipment, net
125 123 126 121 112 107 95 91 85 81 107
Total Noncurrent Assets
235 226 295 280 327 196 174 159 159 142 162
Goodwill
115 115 126 125 145 58 58 58 58 58 63
Intangible Assets
108 98 153 133 127 110 94 79 65 52 55
Other Noncurrent Operating Assets
11 13 16 21 55 28 21 22 35 31 44
Total Liabilities & Shareholders' Equity
609 604 736 775 783 620 609 615 634 649 707
Total Liabilities
309 267 406 388 394 349 353 375 384 393 567
Total Current Liabilities
104 87 103 128 121 94 119 152 143 156 141
Accounts Payable
39 36 55 66 61 26 35 64 61 43 41
Current Deferred Revenue
39 23 20 27 31 25 27 33 22 27 26
Other Current Liabilities
- - 0.00 0.91 4.52 5.00 6.78 4.44 5.07 4.70 74
Total Noncurrent Liabilities
205 180 303 260 273 256 234 223 241 237 425
Long-Term Debt
167 145 269 232 188 173 163 160 159 169 334
Other Noncurrent Operating Liabilities
1.67 1.41 2.91 1.92 54 47 38 36 51 42 91
Total Equity & Noncontrolling Interests
301 337 330 387 389 270 257 240 250 256 140
Total Preferred & Common Equity
301 337 330 387 389 270 257 240 250 256 140
Total Common Equity
300 337 330 386 389 270 257 240 250 256 140
Common Stock
58 65 68 73 77 82 92 99 130 145 0.39
Accumulated Other Comprehensive Income / (Loss)
-15 -15 -13 -13 -16 -16 -14 -9.53 -9.43 -3.86 -4.41
Other Equity Adjustments
- - - - - - - - - - 144

Quarterly Balance Sheets for Astronics

This table presents Astronics' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 10/1/2022 4/1/2023 7/1/2023 9/30/2023 3/30/2024 6/29/2024 9/28/2024 3/29/2025 6/28/2025 9/27/2025 4/4/2026
Total Assets
599 616 654 631 630 645 652 662 647 682 747
Total Current Assets
347 374 398 381 392 412 424 432 419 433 469
Cash & Equivalents
2.57 4.22 3.47 3.98 5.31 2.86 5.18 25 13 13 12
Accounts Receivable
134 152 171 153 170 186 193 194 187 189 217
Inventories, net
190 200 207 204 199 201 205 198 194 197 212
Prepaid Expenses
21 16 16 17 16 21 19 15 24 27 28
Plant, Property, & Equipment, net
91 89 88 87 84 83 81 80 83 97 115
Total Noncurrent Assets
161 154 168 163 154 150 146 149 145 153 163
Goodwill
58 58 58 58 58 58 58 58 58 60 64
Intangible Assets
83 76 72 69 62 59 56 50 47 51 52
Other Noncurrent Operating Assets
20 20 37 36 34 33 32 42 40 42 46
Total Liabilities & Shareholders' Equity
599 616 654 631 630 645 652 662 647 682 747
Total Liabilities
362 377 423 398 378 387 402 395 375 573 585
Total Current Liabilities
133 147 174 158 151 141 150 158 138 151 158
Accounts Payable
53 63 80 70 61 56 57 45 46 52 56
Current Deferred Revenue
29 27 27 26 20 18 19 30 27 27 30
Other Current Liabilities
51 49 58 54 61 66 73 82 65 73 72
Total Noncurrent Liabilities
228 231 249 240 227 246 252 238 237 422 428
Long-Term Debt
159 166 169 160 153 173 178 160 159 334 335
Other Noncurrent Operating Liabilities
69 65 80 80 74 73 74 78 78 88 93
Total Equity & Noncontrolling Interests
237 239 230 232 252 258 249 267 272 109 162
Total Preferred & Common Equity
237 239 230 232 252 258 249 267 272 109 162
Total Common Equity
237 239 230 232 252 258 249 267 272 109 162
Common Stock
0.35 0.36 0.36 0.37 0.38 0.38 0.38 0.38 0.38 0.38 0.39
Accumulated Other Comprehensive Income / (Loss)
-17 -9.12 -8.44 -9.09 -9.90 -9.79 -8.46 -3.35 -1.40 -2.02 -5.44
Other Equity Adjustments
253 248 238 241 261 267 257 270 273 111 167

Annual Metrics And Ratios for Astronics

This table displays calculated financial ratios and metrics derived from Astronics' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - - - 35,629,121.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 35,629,121.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.82
Growth Metrics
- - - - - - - - - - -
Revenue Growth
4.73% -8.55% -1.37% 28.63% -3.80% -34.96% -11.48% 20.23% 28.85% 15.41% 8.39%
EBITDA Growth
8.28% -20.29% -41.96% 68.96% 10.79% -168.67% 111.99% -16.31% 253.01% 98.67% 96.43%
EBIT Growth
13.09% -25.97% -58.49% 104.19% 20.09% -241.94% 80.93% -1.07% 85.36% 913.91% 217.76%
NOPAT Growth
13.42% -25.07% -52.05% 125.46% -97.73% -5,541.54% 71.53% -4.78% 77.80% 496.73% 279.06%
Net Income Growth
19.23% -27.70% -59.36% 137.83% 11.14% -322.58% 77.91% -39.76% 26.09% 38.63% 281.06%
EPS Growth
19.23% -36.94% -58.57% 143.10% 13.48% -335.00% 78.19% -35.37% 27.93% 42.50% 276.09%
Operating Cash Flow Growth
-21.40% -37.77% -22.66% 45.25% -22.22% -12.54% -114.81% -411.97% 15.41% 227.62% 144.70%
Free Cash Flow Firm Growth
182.62% 310.48% -348.85% 161.81% -24.69% 65.99% -109.92% -206.41% 1.69% 188.84% 8.55%
Invested Capital Growth
15.76% 3.59% 24.83% 0.15% -7.01% -25.88% -3.25% 0.08% 4.18% -0.02% 12.31%
Revenue Q/Q Growth
-1.25% -0.51% 2.84% 4.10% -0.58% -14.26% 0.28% 8.54% 5.70% 1.69% 3.80%
EBITDA Q/Q Growth
-6.84% -0.72% -30.09% 37.69% -35.48% 31.99% 291.38% -41.17% 77.66% -0.81% 38.38%
EBIT Q/Q Growth
-8.78% -0.77% -46.30% 72.59% -44.50% 25.32% 26.57% -32.52% 78.79% 1.77% 56.13%
NOPAT Q/Q Growth
-5.85% -5.48% -37.79% 41.80% -97.07% 23.76% -12.89% 15.66% 62.14% 4.31% 112.64%
Net Income Q/Q Growth
-6.34% -7.67% -44.12% 63.28% -47.23% 10.84% 45.77% -30.64% 34.24% -153.08% 1,050.74%
EPS Q/Q Growth
-6.34% -22.65% -53.97% 58.43% -49.84% 8.29% 46.41% -32.14% 34.96% -170.59% 1,112.50%
Operating Cash Flow Q/Q Growth
5.37% -19.22% -17.89% 78.02% -38.81% -15.07% 56.38% -8.18% -109.23% 1,134.99% 1.64%
Free Cash Flow Firm Q/Q Growth
145.20% -20.26% -524.18% 166.28% -52.17% 18.13% -181.00% -28.12% -66.84% 280.83% 103.63%
Invested Capital Q/Q Growth
-3.96% -2.59% 16.92% -6.34% -6.28% -5.89% -2.98% -0.86% 3.22% -3.67% 7.79%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
27.15% 25.19% 21.96% 22.50% 20.21% 19.27% 14.69% 13.37% 17.53% 21.16% 29.94%
EBITDA Margin
17.93% 15.63% 9.20% 12.08% 13.91% -14.69% 1.99% 1.38% 3.79% 6.53% 11.83%
Operating Margin
14.27% 11.83% 5.14% 7.93% 0.22% -20.04% -6.44% -5.62% -0.97% 3.33% 8.86%
EBIT Margin
14.27% 11.55% 4.86% 7.72% 9.63% -21.03% -4.53% -3.81% -0.43% 3.05% 8.95%
Profit (Net Income) Margin
9.67% 7.65% 3.15% 5.83% 6.73% -23.04% -5.75% -6.68% -3.83% -2.04% 3.41%
Tax Burden Percent
71.21% 70.40% 78.74% 89.52% 76.16% 103.00% 94.87% 119.98% 100.42% 206.11% 91.90%
Interest Burden Percent
95.19% 94.05% 82.32% 84.34% 91.75% 106.38% 133.76% 146.25% 882.03% -32.40% 41.41%
Effective Tax Rate
28.79% 29.60% 21.26% 10.48% 23.84% 0.00% 0.00% 0.00% 0.00% 0.00% 8.10%
Return on Invested Capital (ROIC)
16.72% 11.47% 4.81% 9.76% 0.23% -14.89% -5.06% -5.39% -1.17% 4.56% 16.28%
ROIC Less NNEP Spread (ROIC-NNEP)
14.56% 8.42% 1.89% 5.25% 28.98% -46.41% -9.21% -15.78% -15.34% -18.06% -1.24%
Return on Net Nonoperating Assets (RNNOA)
8.61% 3.71% 1.09% 3.31% 13.19% -20.23% -4.64% -9.01% -9.62% -10.97% -1.46%
Return on Equity (ROE)
25.34% 15.18% 5.90% 13.06% 13.42% -35.13% -9.71% -14.40% -10.80% -6.41% 14.82%
Cash Return on Invested Capital (CROIC)
2.11% 7.94% -17.28% 9.61% 7.50% 14.83% -1.76% -5.47% -5.26% 4.58% 4.69%
Operating Return on Assets (OROA)
16.86% 12.05% 4.53% 8.21% 9.56% -15.07% -3.28% -3.33% -0.48% 3.79% 11.38%
Return on Assets (ROA)
11.43% 7.98% 2.94% 6.20% 6.68% -16.51% -4.16% -5.84% -4.23% -2.53% 4.33%
Return on Common Equity (ROCE)
25.31% 15.17% 5.89% 13.05% 13.41% -35.11% -9.70% -14.40% -10.80% -6.41% 14.82%
Return on Equity Simple (ROE_SIMPLE)
22.29% 14.35% 5.96% 12.11% 13.38% -42.82% -9.97% -14.90% -10.59% -6.33% 0.00%
Net Operating Profit after Tax (NOPAT)
70 53 25 57 1.30 -70 -20 -21 -4.67 19 70
NOPAT Margin
10.16% 8.33% 4.05% 7.10% 0.17% -14.03% -4.51% -3.93% -0.68% 2.33% 8.15%
Net Nonoperating Expense Percent (NNEP)
2.16% 3.05% 2.92% 4.51% -28.76% 31.52% 4.14% 10.38% 14.16% 22.62% 17.52%
Return On Investment Capital (ROIC_SIMPLE)
14.96% 10.86% 4.20% 9.18% 0.22% -15.90% -4.78% -5.21% -1.12% 4.36% 14.80%
Cost of Revenue to Revenue
72.85% 74.81% 78.04% 77.50% 79.79% 80.73% 85.31% 86.63% 82.47% 78.84% 70.06%
SG&A Expenses to Revenue
12.88% 13.36% 14.22% 14.57% 18.55% 21.99% 22.26% 18.99% 18.49% 17.84% 16.04%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.04%
Operating Expenses to Revenue
12.88% 13.36% 16.82% 14.57% 19.99% 39.31% 21.14% 18.99% 18.49% 17.84% 21.08%
Earnings before Interest and Taxes (EBIT)
99 73 30 62 74 -106 -20 -20 -2.98 24 77
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
124 99 57 97 107 -74 8.85 7.41 26 52 102
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.46 2.91 3.52 2.55 2.22 1.51 1.47 1.38 2.37 2.20 13.80
Price to Tangible Book Value (P/TBV)
13.57 7.94 23.02 7.69 7.40 4.00 3.63 3.23 4.70 3.87 88.66
Price to Revenue (P/Rev)
1.50 1.55 1.86 1.23 1.12 0.81 0.85 0.62 0.86 0.71 2.24
Price to Earnings (P/E)
15.52 20.29 59.01 21.02 16.59 0.00 0.00 0.00 0.00 0.00 65.82
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
6.44% 4.93% 1.69% 4.76% 6.03% 0.00% 0.00% 0.00% 0.00% 0.00% 1.52%
Enterprise Value to Invested Capital (EV/IC)
2.64 2.38 2.42 2.05 1.87 1.34 1.31 1.23 1.84 1.75 4.93
Enterprise Value to Revenue (EV/Rev)
1.72 1.76 2.27 1.50 1.32 1.07 1.15 0.90 1.09 0.90 2.61
Enterprise Value to EBITDA (EV/EBITDA)
9.59 11.25 24.64 12.38 9.48 0.00 57.72 65.03 28.62 13.73 22.04
Enterprise Value to EBIT (EV/EBIT)
12.05 15.22 46.61 19.38 13.69 0.00 0.00 0.00 0.00 29.37 29.15
Enterprise Value to NOPAT (EV/NOPAT)
16.92 21.11 55.98 21.08 786.79 0.00 0.00 0.00 0.00 38.49 32.02
Enterprise Value to Operating Cash Flow (EV/OCF)
15.17 22.78 37.45 21.89 23.88 14.47 0.00 0.00 0.00 23.33 30.07
Enterprise Value to Free Cash Flow (EV/FCFF)
133.90 30.49 0.00 21.40 24.10 7.69 0.00 0.00 0.00 38.28 111.22
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.57 0.44 0.82 0.61 0.48 0.64 0.64 0.68 0.67 0.66 2.39
Long-Term Debt to Equity
0.56 0.43 0.82 0.60 0.48 0.64 0.64 0.66 0.64 0.66 2.39
Financial Leverage
0.59 0.44 0.58 0.63 0.45 0.44 0.50 0.57 0.63 0.61 1.18
Leverage Ratio
2.22 1.90 2.01 2.11 2.01 2.13 2.33 2.47 2.55 2.54 3.42
Compound Leverage Factor
2.11 1.79 1.65 1.78 1.84 2.26 3.12 3.61 22.51 -0.82 1.42
Debt to Total Capital
36.10% 30.50% 45.17% 37.70% 32.62% 39.02% 38.85% 40.60% 40.27% 39.71% 70.48%
Short-Term Debt to Total Capital
0.55% 0.54% 0.45% 0.30% 0.04% 0.00% 0.00% 1.11% 2.15% 0.00% 0.00%
Long-Term Debt to Total Capital
35.55% 29.96% 44.72% 37.40% 32.58% 39.02% 38.85% 39.49% 38.12% 39.71% 70.48%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
63.84% 69.43% 54.78% 62.24% 67.38% 60.90% 61.15% 59.40% 59.73% 60.29% 29.52%
Debt to EBITDA
1.37 1.50 4.73 2.41 1.75 -2.34 18.42 22.14 6.43 3.25 3.28
Net Debt to EBITDA
1.22 1.32 4.42 2.24 1.45 -1.80 15.06 20.28 6.00 2.89 3.10
Long-Term Debt to EBITDA
1.35 1.47 4.69 2.39 1.75 -2.34 18.42 21.54 6.09 3.25 3.28
Debt to NOPAT
2.41 2.81 10.75 4.11 145.30 -2.45 -8.12 -7.80 -36.03 9.10 4.76
Net Debt to NOPAT
2.15 2.47 10.04 3.81 120.67 -1.88 -6.64 -7.14 -33.60 8.11 4.50
Long-Term Debt to NOPAT
2.38 2.76 10.64 4.07 145.13 -2.45 -8.12 -7.58 -34.10 9.10 4.76
Altman Z-Score
4.57 4.70 3.67 3.88 3.72 2.09 2.36 2.25 2.93 2.71 4.56
Noncontrolling Interest Sharing Ratio
0.10% 0.09% 0.10% 0.10% 0.04% 0.05% 0.07% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.40 2.95 3.06 2.92 2.84 3.38 2.87 2.41 2.72 2.73 3.10
Quick Ratio
1.09 1.47 1.46 1.55 1.49 1.42 1.16 1.07 1.23 1.29 1.58
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
8.89 37 -91 56 42 70 -6.96 -21 -21 19 20
Operating Cash Flow to CapEx
421.12% 374.73% 280.33% 336.34% 353.30% 500.54% -91.65% -368.89% -313.36% 362.67% 236.15%
Free Cash Flow to Firm to Interest Expense
1.87 8.38 -16.92 5.78 6.89 10.41 -1.02 0.00 0.00 1.84 0.62
Operating Cash Flow to Interest Expense
16.52 11.22 7.04 5.65 6.95 5.54 -0.81 0.00 0.00 3.01 2.29
Operating Cash Flow Less CapEx to Interest Expense
12.60 8.23 4.53 3.97 4.98 4.43 -1.70 0.00 0.00 2.18 1.32
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.18 1.04 0.93 1.06 0.99 0.72 0.72 0.87 1.10 1.24 1.27
Accounts Receivable Turnover
7.52 6.19 5.16 5.10 4.68 4.17 4.44 4.19 4.31 4.38 4.35
Inventory Turnover
4.38 4.08 3.65 4.31 4.33 2.68 2.41 2.68 2.99 3.20 3.05
Fixed Asset Turnover
5.74 5.12 5.02 6.51 6.62 4.59 4.41 5.75 7.83 9.58 9.18
Accounts Payable Turnover
12.86 12.70 10.66 10.22 9.68 9.28 12.38 9.36 9.07 12.05 14.37
Days Sales Outstanding (DSO)
48.55 59.00 70.74 71.55 78.01 87.53 82.24 87.08 84.71 83.41 83.85
Days Inventory Outstanding (DIO)
83.42 89.41 99.91 84.68 84.20 136.22 151.29 136.10 121.94 113.95 119.84
Days Payable Outstanding (DPO)
28.38 28.75 34.23 35.72 37.70 39.32 29.48 39.01 40.24 30.29 25.39
Cash Conversion Cycle (CCC)
103.59 119.67 136.42 120.52 124.52 184.43 204.05 184.17 166.41 167.07 178.30
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
451 468 584 585 544 403 390 390 406 406 456
Invested Capital Turnover
1.65 1.38 1.19 1.38 1.37 1.06 1.12 1.37 1.73 1.96 2.00
Increase / (Decrease) in Invested Capital
61 16 116 0.85 -41 -141 -13 0.30 16 -0.10 50
Enterprise Value (EV)
1,191 1,113 1,415 1,201 1,019 540 511 482 748 713 2,249
Market Capitalization
1,039 983 1,161 984 863 407 378 331 591 563 1,933
Book Value per Share
$11.76 $11.61 $11.77 $11.95 $12.60 $8.77 $8.16 $7.46 $7.35 $7.26 $3.93
Tangible Book Value per Share
$3.00 $4.26 $1.80 $3.96 $3.78 $3.31 $3.31 $3.19 $3.71 $4.13 $0.61
Total Capital
470 486 602 621 577 443 420 404 418 425 475
Total Debt
170 148 272 234 188 173 163 164 168 169 334
Total Long-Term Debt
167 145 269 232 188 173 163 160 159 169 334
Net Debt
151 130 254 217 156 133 133 150 157 150 316
Capital Expenditures (CapEx)
19 13 13 16 12 7.46 6.03 7.68 7.64 8.43 32
Debt-free, Cash-free Net Working Capital (DFCFNWC)
130 153 197 231 191 183 191 204 244 252 278
Debt-free Net Working Capital (DFNWC)
148 171 215 248 223 223 221 218 255 270 296
Net Working Capital (NWC)
146 169 212 246 222 223 221 214 246 270 296
Net Nonoperating Expense (NNE)
3.38 4.29 5.60 10 -51 45 5.51 15 22 35 41
Net Nonoperating Obligations (NNO)
151 130 254 198 155 133 133 150 157 150 316
Total Depreciation and Amortization (D&A)
25 26 27 35 33 32 29 28 29 28 25
Debt-free, Cash-free Net Working Capital to Revenue
18.74% 24.21% 31.58% 28.80% 24.69% 36.37% 43.04% 38.21% 35.42% 31.63% 32.28%
Debt-free Net Working Capital to Revenue
21.42% 27.03% 34.45% 30.87% 28.82% 44.41% 49.73% 40.79% 37.06% 33.95% 34.39%
Net Working Capital to Revenue
21.05% 26.62% 34.02% 30.64% 28.79% 44.41% 49.73% 39.95% 35.76% 33.95% 34.39%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.36 $1.66 $0.69 $1.45 $1.62 ($3.76) ($0.82) ($1.11) ($0.80) ($0.46) $0.83
Adjusted Weighted Average Basic Shares Outstanding
28.58M 29.10M 28.07M 32.60M 30.72M 30.89M 31.52M 64.57M 34.52M 35.27M 35.69M
Adjusted Diluted Earnings per Share
$2.28 $1.61 $0.67 $1.41 $1.60 ($3.76) ($0.82) ($1.11) ($0.80) ($0.46) $0.81
Adjusted Weighted Average Diluted Shares Outstanding
28.58M 29.10M 28.07M 32.60M 30.72M 30.89M 31.52M 64.57M 34.52M 35.27M 35.69M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
28.58M 29.10M 28.07M 32.60M 30.72M 30.89M 31.52M 64.57M 34.52M 35.27M 35.69M
Normalized Net Operating Profit after Tax (NOPAT)
70 53 38 57 9.74 -9.58 -24 -21 -4.67 19 70
Normalized NOPAT Margin
10.16% 8.33% 6.10% 7.10% 1.26% -1.91% -5.30% -3.93% -0.68% 2.33% 8.15%
Pre Tax Income Margin
13.59% 10.86% 4.00% 6.51% 8.84% -22.37% -6.06% -5.57% -3.82% -0.99% 3.71%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
20.80 16.80 5.65 6.38 12.12 -15.68 -2.96 0.00 0.00 2.39 2.36
NOPAT to Interest Expense
14.81 12.11 4.71 5.87 0.21 -10.46 -2.95 0.00 0.00 1.83 2.15
EBIT Less CapEx to Interest Expense
16.87 13.80 3.14 4.70 10.15 -16.78 -3.85 0.00 0.00 1.56 1.39
NOPAT Less CapEx to Interest Expense
10.89 9.11 2.20 4.19 -1.76 -11.56 -3.84 0.00 0.00 1.00 1.18
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 36.38% 164.55% 0.00% 97.63% -6.68% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Astronics

This table displays calculated financial ratios and metrics derived from Astronics' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/30/2024 6/29/2024 9/28/2024 12/31/2024 3/29/2025 6/28/2025 9/27/2025 12/31/2025 4/4/2026
DEI Shares Outstanding
- - - - - - - - - 35,629,121.00 35,691,175.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 35,629,121.00 35,691,175.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.83 0.72
Growth Metrics
- - - - - - - - - - -
Revenue Growth
23.95% 23.48% 18.23% 13.56% 25.03% 6.78% 11.27% 3.31% 3.80% 15.12% 11.99%
EBITDA Growth
3.37% 349.05% -12.81% 49.65% 297.05% -2.87% 132.59% -22.87% 92.17% 198.17% 72.30%
EBIT Growth
-0.58% 307.92% -47.55% 252.58% 154.16% 5.64% 983.25% -30.46% 189.38% 350.94% 103.55%
NOPAT Growth
-1.15% 1,696.34% 170.30% 448.12% 157.84% -223.31% 954.95% -63.26% 175.32% 174.63% 128.07%
Net Income Growth
-14.31% 202.91% 28.02% 112.78% 30.88% -140.60% 399.81% -14.29% 5.45% 1,145.73% 168.05%
EPS Growth
-10.87% 204.76% 35.71% 110.81% 33.33% -131.82% 388.89% 0.00% 8.82% 1,271.43% 157.69%
Operating Cash Flow Growth
96.10% -115.46% 110.62% -217.77% 844.18% 1,678.08% 913.35% -21.95% 308.07% 4.57% -48.62%
Free Cash Flow Firm Growth
-498.99% 860.12% 98.44% 44.78% -114.13% -328.04% 3,604.49% 192.96% 165.79% 59.95% -399.07%
Invested Capital Growth
0.06% 4.18% 0.42% 5.85% 7.13% -0.02% -1.56% -2.35% 0.36% 12.31% 20.90%
Revenue Q/Q Growth
-6.61% 19.87% -5.23% 7.05% 2.82% 2.38% -1.25% -0.61% 3.31% 13.54% -3.94%
EBITDA Q/Q Growth
-180.80% 292.01% -42.93% 69.02% 6.40% -5.36% 36.65% -43.95% 165.08% 46.85% -21.03%
EBIT Q/Q Growth
-834.74% 150.46% -83.56% 478.46% 12.87% -1.59% 68.59% -62.86% 369.68% 53.35% -23.90%
NOPAT Q/Q Growth
-704.30% 449.17% -96.70% 688.30% -36.24% -844.49% 128.19% -72.55% 377.80% 101.82% -13.85%
Net Income Q/Q Growth
-41.54% 141.08% -145.56% 148.24% -865.69% 75.87% 436.44% -86.21% -944.60% 366.85% -13.76%
EPS Q/Q Growth
-37.84% 143.14% -140.91% 144.44% -950.00% 79.41% 471.43% -84.62% -875.00% 364.52% -18.29%
Operating Cash Flow Q/Q Growth
42.89% -48.80% 221.68% -407.31% 233.74% 215.54% -21.86% -136.98% 547.52% -19.15% -61.60%
Free Cash Flow Firm Q/Q Growth
60.33% 284.17% -102.79% -2,613.40% -53.84% -96.13% 142.80% -28.03% 8.88% -219.39% -219.66%
Invested Capital Q/Q Growth
-2.49% 3.22% 0.20% 4.95% -1.31% -3.67% -1.33% 4.11% 1.43% 7.79% 6.22%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
12.66% 20.47% 25.67% 20.87% 20.98% 24.00% 29.55% 25.81% 30.51% 33.31% 32.58%
EBITDA Margin
-4.70% 7.53% 4.53% 7.16% 7.41% 6.85% 9.48% 5.34% 13.71% 17.74% 14.58%
Operating Margin
-8.89% 3.98% 0.90% 3.81% 4.11% 4.26% 6.38% 2.32% 10.90% 14.77% 11.81%
EBIT Margin
-9.10% 3.83% 0.66% 3.59% 3.94% 3.79% 6.47% 2.42% 10.99% 14.85% 11.76%
Profit (Net Income) Margin
-10.42% 3.57% -1.72% 0.77% -5.76% -1.36% 4.63% 0.64% -5.25% 12.34% 11.07%
Tax Burden Percent
81.58% 454.76% 70.17% 121.76% 226.91% -491.67% 93.65% 70.99% 90.05% 91.85% 103.05%
Interest Burden Percent
140.41% 20.51% -368.21% 17.70% -64.41% 7.29% 76.36% 37.41% -53.03% 90.48% 91.39%
Effective Tax Rate
0.00% -354.76% 0.00% -21.76% 0.00% 591.67% 6.35% 29.01% 0.00% 8.15% -3.05%
Return on Invested Capital (ROIC)
-10.31% 31.36% 1.11% 8.28% 5.52% -40.96% 12.07% 3.21% 15.00% 27.12% 24.37%
ROIC Less NNEP Spread (ROIC-NNEP)
-14.61% 12.86% -1.58% 3.81% -5.02% -14.39% 10.15% 1.91% 3.82% 25.85% 23.26%
Return on Net Nonoperating Assets (RNNOA)
-9.89% 8.07% -1.04% 2.68% -3.48% -8.74% 5.67% 1.14% 5.19% 30.44% 24.82%
Return on Equity (ROE)
-20.20% 39.42% 0.07% 10.95% 2.04% -49.70% 17.74% 4.35% 20.19% 57.56% 49.19%
Cash Return on Invested Capital (CROIC)
-3.19% -5.26% -0.87% -5.26% -2.53% 4.58% -3.25% -1.80% -131.81% 4.69% 0.99%
Operating Return on Assets (OROA)
-9.65% 4.23% 0.77% 4.10% 4.81% 4.70% 8.17% 3.08% 13.69% 18.88% 14.80%
Return on Assets (ROA)
-11.05% 3.94% -1.98% 0.88% -7.03% -1.68% 5.85% 0.82% -6.54% 15.69% 13.94%
Return on Common Equity (ROCE)
-20.20% 39.42% 0.07% 10.95% 2.04% -49.70% 17.74% 4.35% 20.19% 57.56% 49.19%
Return on Equity Simple (ROE_SIMPLE)
-17.29% 0.00% -10.00% -4.52% -2.57% 0.00% -1.32% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-10 35 1.17 9.19 5.86 -44 12 3.38 16 33 28
NOPAT Margin
-6.22% 18.12% 0.63% 4.64% 2.88% -20.93% 5.97% 1.65% 7.63% 13.57% 12.17%
Net Nonoperating Expense Percent (NNEP)
4.31% 18.50% 2.70% 4.47% 10.54% -26.57% 1.92% 1.31% 11.18% 1.27% 1.10%
Return On Investment Capital (ROIC_SIMPLE)
-2.53% 8.47% 0.28% 2.13% 1.37% -10.27% 2.88% 0.78% 3.64% 6.86% 5.65%
Cost of Revenue to Revenue
87.34% 79.53% 74.33% 79.13% 79.02% 76.00% 70.45% 74.19% 69.49% 66.69% 67.42%
SG&A Expenses to Revenue
21.54% 16.48% 17.57% 17.06% 16.87% 19.75% 17.79% 17.83% 14.78% 14.11% 15.53%
R&D to Revenue
0.00% 0.00% 7.20% 0.00% 0.00% 0.00% 5.37% 5.65% 4.83% 4.43% 5.24%
Operating Expenses to Revenue
21.54% 16.48% 24.77% 17.06% 16.87% 19.75% 23.17% 23.49% 19.61% 18.54% 20.77%
Earnings before Interest and Taxes (EBIT)
-15 7.48 1.23 7.12 8.03 7.90 13 4.95 23 36 27
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-7.66 15 8.39 14 15 14 20 11 29 43 34
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.22 2.37 2.61 2.71 2.82 2.20 3.26 4.36 14.54 13.80 15.42
Price to Tangible Book Value (P/TBV)
4.89 4.70 5.00 4.95 5.18 3.87 5.47 7.10 0.00 88.66 55.35
Price to Revenue (P/Rev)
0.79 0.86 0.92 0.94 0.90 0.71 1.07 1.44 1.91 2.24 2.81
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 65.82 54.94
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.52% 1.82%
Enterprise Value to Invested Capital (EV/IC)
1.72 1.84 2.00 2.03 2.07 1.75 2.50 3.19 4.48 4.93 5.81
Enterprise Value to Revenue (EV/Rev)
1.04 1.09 1.13 1.17 1.12 0.90 1.23 1.62 2.28 2.61 3.18
Enterprise Value to EBITDA (EV/EBITDA)
46.03 28.62 32.63 29.29 16.70 13.73 15.92 22.23 25.74 22.04 24.25
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 868.29 36.64 29.37 27.61 38.88 38.40 29.15 30.96
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 491.93 49.22 38.49 0.00 0.00 0.00 32.02 31.92
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 353.21 23.33 20.42 27.82 25.78 30.07 43.48
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 38.28 0.00 0.00 0.00 111.22 639.15
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.73 0.67 0.64 0.67 0.72 0.66 0.60 0.59 3.07 2.39 2.07
Long-Term Debt to Equity
0.69 0.64 0.61 0.67 0.72 0.66 0.60 0.59 3.07 2.39 2.07
Financial Leverage
0.68 0.63 0.66 0.70 0.69 0.61 0.56 0.60 1.36 1.18 1.07
Leverage Ratio
2.62 2.55 2.54 2.66 2.66 2.54 2.49 2.44 3.72 3.42 3.29
Compound Leverage Factor
3.68 0.52 -9.35 0.47 -1.72 0.18 1.90 0.91 -1.98 3.10 3.01
Debt to Total Capital
42.10% 40.27% 39.18% 40.28% 41.80% 39.71% 37.51% 36.97% 75.41% 70.48% 67.44%
Short-Term Debt to Total Capital
2.24% 2.15% 2.17% 0.30% 0.13% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
39.86% 38.12% 37.00% 39.98% 41.67% 39.71% 37.51% 36.97% 75.41% 70.48% 67.44%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
57.90% 59.73% 60.82% 59.72% 58.20% 60.29% 62.49% 63.03% 24.59% 29.52% 32.56%
Debt to EBITDA
11.48 6.43 6.51 5.87 3.42 3.25 2.54 2.66 4.53 3.28 2.88
Net Debt to EBITDA
10.96 6.00 6.24 5.72 3.30 2.89 2.13 2.44 4.27 3.10 2.78
Long-Term Debt to EBITDA
10.87 6.09 6.15 5.83 3.41 3.25 2.54 2.66 4.53 3.28 2.88
Debt to NOPAT
-13.70 -36.03 -87.91 98.64 10.08 9.10 -8.22 -9.03 -0.60 4.76 3.80
Net Debt to NOPAT
-13.08 -33.60 -84.32 96.15 9.72 8.11 -6.89 -8.27 -0.57 4.50 3.66
Long-Term Debt to NOPAT
-12.97 -34.10 -83.03 97.90 10.05 9.10 -8.22 -9.03 -0.60 4.76 3.80
Altman Z-Score
2.16 2.98 2.65 2.77 2.79 3.04 3.12 3.71 3.48 4.37 4.36
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.41 2.72 2.59 2.92 2.83 2.73 2.74 3.04 2.87 3.10 2.97
Quick Ratio
0.99 1.23 1.16 1.34 1.32 1.29 1.39 1.46 1.34 1.58 1.45
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-10 19 -0.53 -14 -22 -44 19 13 15 -17 -56
Operating Cash Flow to CapEx
-50.43% -104.23% 127.47% -348.55% 452.54% 829.68% 980.62% -165.78% 259.80% 233.84% 95.04%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 -3.18 0.00 0.00 0.00 0.45 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 1.20 0.00 0.00 0.00 1.05 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.93 0.00 0.00 0.00 0.64 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.06 1.10 1.15 1.14 1.22 1.24 1.26 1.27 1.25 1.27 1.26
Accounts Receivable Turnover
4.55 4.31 4.45 4.15 4.52 4.38 4.48 4.41 4.35 4.35 4.31
Inventory Turnover
2.79 2.99 2.89 2.97 3.05 3.20 3.19 3.26 3.19 3.05 3.00
Fixed Asset Turnover
7.35 7.83 8.33 8.71 9.31 9.58 9.95 9.93 9.34 9.18 9.05
Accounts Payable Turnover
8.96 9.07 9.27 8.90 9.86 12.05 11.91 12.61 11.81 14.37 12.15
Days Sales Outstanding (DSO)
80.27 84.71 82.03 87.90 80.84 83.41 81.44 82.85 83.96 83.85 84.59
Days Inventory Outstanding (DIO)
130.83 121.94 126.35 123.06 119.59 113.95 114.29 111.95 114.28 119.84 121.76
Days Payable Outstanding (DPO)
40.76 40.24 39.39 41.01 37.04 30.29 30.64 28.95 30.89 25.39 30.05
Cash Conversion Cycle (CCC)
170.34 166.41 168.99 169.95 163.39 167.07 165.10 165.85 167.34 178.30 176.30
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
394 406 407 427 422 406 401 417 423 456 485
Invested Capital Turnover
1.66 1.73 1.77 1.78 1.92 1.96 2.02 1.95 1.97 2.00 2.00
Increase / (Decrease) in Invested Capital
0.23 16 1.70 24 28 -0.10 -6.33 -10 1.53 50 84
Enterprise Value (EV)
677 748 813 867 874 713 1,004 1,330 1,897 2,249 2,816
Market Capitalization
516 591 657 698 702 563 870 1,184 1,583 1,933 2,493
Book Value per Share
$7.14 $7.35 $7.29 $7.40 $7.12 $7.26 $7.56 $7.67 $3.08 $3.93 $4.53
Tangible Book Value per Share
$3.24 $3.71 $3.81 $4.04 $3.87 $4.13 $4.51 $4.71 ($0.05) $0.61 $1.26
Total Capital
401 418 414 432 428 425 427 431 443 475 497
Total Debt
169 168 162 174 179 169 160 159 334 334 335
Total Long-Term Debt
160 159 153 173 178 169 160 159 334 334 335
Net Debt
161 157 156 170 173 150 134 146 314 316 323
Capital Expenditures (CapEx)
2.23 1.61 1.60 1.80 1.85 3.18 2.11 4.61 13 12 11
Debt-free, Cash-free Net Working Capital (DFCFNWC)
224 244 243 268 268 252 249 267 262 278 299
Debt-free Net Working Capital (DFNWC)
232 255 250 273 275 270 275 281 282 296 311
Net Working Capital (NWC)
223 246 241 271 274 270 275 281 282 296 311
Net Nonoperating Expense (NNE)
6.85 28 4.34 7.66 18 -41 2.77 2.06 27 2.96 2.52
Net Nonoperating Obligations (NNO)
161 157 156 170 173 150 134 146 314 316 323
Total Depreciation and Amortization (D&A)
7.17 7.22 7.16 7.07 7.06 6.38 6.19 5.99 5.75 6.94 6.50
Debt-free, Cash-free Net Working Capital to Revenue
34.41% 35.42% 33.86% 36.17% 34.31% 31.63% 30.47% 32.49% 31.55% 32.28% 33.72%
Debt-free Net Working Capital to Revenue
35.58% 37.06% 34.78% 36.76% 35.12% 33.95% 33.65% 34.13% 33.91% 34.39% 35.06%
Net Working Capital to Revenue
34.20% 35.76% 33.52% 36.59% 35.05% 33.95% 33.65% 34.13% 33.91% 34.39% 35.06%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.51) $0.22 ($0.09) $0.04 ($0.34) ($0.07) $0.27 $0.04 ($0.31) $0.83 $0.71
Adjusted Weighted Average Basic Shares Outstanding
33.94M 34.52M 34.84M 34.99M 35.26M 35.27M 35.41M 35.41M 35.63M 35.69M 35.84M
Adjusted Diluted Earnings per Share
($0.51) $0.22 ($0.09) $0.04 ($0.34) ($0.07) $0.26 $0.04 ($0.31) $0.82 $0.67
Adjusted Weighted Average Diluted Shares Outstanding
33.94M 34.52M 34.84M 34.99M 35.26M 35.27M 35.41M 35.41M 35.63M 35.69M 35.84M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
33.94M 34.52M 34.84M 34.99M 35.26M 35.27M 35.41M 35.41M 35.63M 35.69M 35.84M
Normalized Net Operating Profit after Tax (NOPAT)
-10 5.45 1.17 5.29 5.86 6.21 12 3.38 16 33 19
Normalized NOPAT Margin
-6.22% 2.79% 0.63% 2.67% 2.88% 2.98% 5.97% 1.65% 7.63% 13.57% 8.27%
Pre Tax Income Margin
-12.78% 0.79% -2.45% 0.64% -2.54% 0.28% 4.94% 0.90% -5.83% 13.43% 10.75%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 1.15 0.00 0.00 0.00 0.71 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.84 0.00 0.00 0.00 0.49 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.88 0.00 0.00 0.00 0.31 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.57 0.00 0.00 0.00 0.09 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Astronics Corp (ATRO) has shown improving top-line momentum and margins in 2025 after a period of volatility, but the company continues to operate with a relatively modest cash buffer and a high debt burden. Below are the key trends from the last four years, focusing on the most relevant quarterly data for investors.

  • Q4 2025 Operating Revenue reached 240.1 million, up about 15% from Q4 2024 (208.5 million), suggesting improving demand or pricing tailwinds into year-end.
  • Gross margin improved to roughly 33% in Q4 2025 (79.97 million gross profit on 240.07 million revenue) versus about 24% a year earlier, indicating better cost discipline or product mix.
  • Net income attributable to common shareholders turned positive in Q4 2025 at about 29.62 million, with basic EPS of 0.83 and diluted EPS of 0.82, a meaningful improvement from several prior quarters.
  • Total operating income in Q4 2025 was 35.46 million, up from prior quarters in 2024 and 2023, signaling improving operating leverage.
  • Net cash from continuing operating activities in Q4 2025 was 27.62 million, reflecting positive cash generation from core operations.
  • Shares outstanding remained fairly stable, with weighted average basic/diluted shares around 35.69 million in Q4 2025 (limited near-term dilution risk).
  • Investing cash flows continued to be negative as a result of ongoing capital expenditures and acquisitions (for example, Q4 2025 investing cash flow around -29.27 million), indicating continued reinvestment in the business.
  • Debt load surged in Q3 2025, with a large debt issuance of about 310 million; long-term debt rose to approximately 334.0 million and total liabilities climbed to about 573.3 million, increasing leverage and interest exposure.
  • Total equity remained modest relative to liabilities (about 108.9 million in Q3 2025) as liabilities far exceed shareholders’ equity, highlighting a thin equity cushion.
  • Cash balances are relatively modest (cash and equivalents around 13.5 million in mid-2025), implying liquidity risk given the debt level and working-capital needs.
05/21/26 04:23 AM ETAI Generated. May Contain Errors.

Astronics Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Astronics' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Astronics' net income appears to be on a downward trend, with a most recent value of $29.36 million in 2025, falling from $66.97 million in 2015. The previous period was -$16.22 million in 2024. View Astronics' forecast to see where analysts expect Astronics to go next.

Astronics' total operating income in 2025 was $76.41 million, based on the following breakdown:
  • Total Gross Profit: $258.16 million
  • Total Operating Expenses: $181.75 million

Over the last 10 years, Astronics' total revenue changed from $692.28 million in 2015 to $862.13 million in 2025, a change of 24.5%.

Astronics' total liabilities were at $566.60 million at the end of 2025, a 44.3% increase from 2024, and a 83.4% increase since 2015.

In the past 10 years, Astronics' cash and equivalents has ranged from $4.76 million in 2023 to $40.41 million in 2020, and is currently $18.18 million as of their latest financial filing in 2025.

Over the last 10 years, Astronics' book value per share changed from 11.76 in 2015 to 3.93 in 2025, a change of -66.6%.



Financial statements for NASDAQ:ATRO last updated on 5/17/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners